Zhang Yan, Mei Jun, Li Jing, Zhang Ying, Zhou Qingbing, Xu Fengqin
Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.
Institute of Geriatric Medicine, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.
Evid Based Complement Alternat Med. 2021 Jun 23;2021:6623657. doi: 10.1155/2021/6623657. eCollection 2021.
Atherosclerotic cardiovascular diseases, in which atherosclerosis (AS) is the main pathologic basis, are currently the primary diseases leading to human deaths. Emerging evidence showed that DNA methylation, which could affect the transcription and expression of critical regulatory genes, has key roles in AS. Aberrant DNA methylation including aberrant hypomethylation and hypermethylation plays key roles in endothelial-cell dysfunction, macrophage inflammation, abnormal proliferation of vascular smooth muscle cells, plaque rupture, and thrombosis in AS. Chinese herbal medicines, including single compounds and formulations, showed light on the treatment of AS through regulating the aberrant DNA methylation in AS. Targeting the aberrant DNA methylation may be one of the most important treatment strategies in the cure and prevention of AS. In this review, we focus on the relationship between DNA methylation and AS, as well as the beneficial effects of Chinese herbal medicines on DNA methylation in AS.
动脉粥样硬化性心血管疾病是以动脉粥样硬化(AS)为主要病理基础的疾病,是目前导致人类死亡的主要疾病。新出现的证据表明,可影响关键调控基因转录和表达的DNA甲基化在AS中起关键作用。异常的DNA甲基化,包括异常低甲基化和高甲基化,在AS的内皮细胞功能障碍、巨噬细胞炎症、血管平滑肌细胞异常增殖、斑块破裂和血栓形成中起关键作用。包括单一化合物和配方在内的中药通过调节AS中异常的DNA甲基化,为AS的治疗带来了希望。针对异常的DNA甲基化可能是治愈和预防AS的最重要治疗策略之一。在这篇综述中,我们重点关注DNA甲基化与AS之间的关系,以及中药对AS中DNA甲基化的有益作用。